Cargando…

Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster

INTRODUCTION: Varicella zoster virus (VZV) is the etiological agent of varicella and herpes zoster (HZ). It has been hypothesised that immune boosting of latently infected persons by contact with varicella reduces the probability of HZ. If true, universal varicella vaccination may increase HZ incide...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Lier, Alies, Lugnér, Anna, Opstelten, Wim, Jochemsen, Petra, Wallinga, Jacco, Schellevis, François, Sanders, Elisabeth, de Melker, Hester, van Boven, Michiel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634630/ https://www.ncbi.nlm.nih.gov/pubmed/26629544 http://dx.doi.org/10.1016/j.ebiom.2015.08.017

Ejemplares similares

Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2010)

Hospitalization due to varicella in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2011)

Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines
por: de Boer, Pieter T., et al.
Publicado: (2018)

Herpes Zoster and Varicella
por: Fordyce, A. Dingwall
Publicado: (1919)

Herpes Zoster and Varicella
por: Chatterjee, Bijoy Krishna
Publicado: (1929)

Intention to vaccinate universally against varicella, rotavirus gastroenteritis, meningococcal B disease and seasonal influenza among parents in the Netherlands: an internet survey
por: van Lier, Alies, et al.
Publicado: (2017)

Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis
por: Lugnér, Anna K, et al.
Publicado: (2012)

Varicella Vaccination Alters the Chronological Trends of Herpes Zoster and Varicella
por: Wu, Po-Yuan, et al.
Publicado: (2013)

Negative attitude and low intention to vaccinate universally against varicella among public health professionals and parents in the Netherlands: two internet surveys
por: van Lier, Alies, et al.
Publicado: (2016)

RELATION OF VARICELLA TO HERPES ZOSTER : I. STATISTICAL OBSERVATIONS.
por: Rivers, T. M., et al.
Publicado: (1929)

Varicella and herpes zoster vaccine development: lessons learned
por: Warren-Gash, Charlotte, et al.
Publicado: (2017)

Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2019)

Variation in loss of immunity shapes influenza epidemics and the impact of vaccination
por: Woolthuis, Rutger G., et al.
Publicado: (2017)

The changing epidemiology of varicella and herpes zoster in Hong Kong before universal varicella vaccination in 2014
por: Chan, D. Y. W., et al.
Publicado: (2018)

Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011
por: van Lier, Alies, et al.
Publicado: (2016)

The positive duration of varicella zoster immunoglobulin M antibody test in herpes zoster
por: Min, Seong-Won, et al.
Publicado: (2016)

Tozinameran: Varicella zoster virus meningitis and herpes zoster infections : case report
Publicado: (2022)

The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting
por: Sauboin, Christophe, et al.
Publicado: (2019)

RELATION OF VARICELLA TO HERPES ZOSTER : II. CLINICAL AND EXPERIMENTAL OBSERVATIONS.
por: Rivers, T. M., et al.
Publicado: (1929)

Herpes Zoster in an Immunocompetent Child without a History of Varicella
por: Shang, Bing-Shiau, et al.
Publicado: (2021)

An adult co-presented with varicella and herpes zoster caused by varicella zoster virus genotype J, China: a case report
por: Xie, Guangcheng, et al.
Publicado: (2020)

Severe Herpes Zoster Following Varicella Vaccination in Immunocompetent Young Children
por: Moodley, Amaran, et al.
Publicado: (2019)

Tozinameran: Herpes varicella-zoster virus infection: 2 case reports
Publicado: (2022)

Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients
por: Tayyar, Ralph, et al.
Publicado: (2023)

Recombinant varicella zoster virus glycoprotein E antigen vaccine for prevention of herpes zoster and postherpetic neuralgia
Publicado: (2021)

The Efficacy of Amenamevir for the Treatment of Disseminated Herpes Zoster Complicated with Probable Varicella-zoster Pneumonia in an Immunocompromised Patient
por: Kobayashi, Hiroki, et al.
Publicado: (2021)

Trends in Hospitalizations With Primary Varicella and Herpes Zoster During the Prevaricella and Initial Postvaricella and Herpes Zoster Vaccine Eras, Connecticut, 1994–2012
por: Humes, Elizabeth A., et al.
Publicado: (2015)

THE ETIOLOGIC AGENTS OF VARICELLA AND HERPES ZOSTER : SEROLOGIC STUDIES WITH THE VIRUSES AS PROPAGATED IN VITRO
por: Weller, Thomas H., et al.
Publicado: (1958)

THE ETIOLOGIC AGENTS OF VARICELLA AND HERPES ZOSTER : ISOLATION, PROPAGATION, AND CULTURAL CHARACTERISTICS IN VITRO
por: Weller, Thomas H., et al.
Publicado: (1958)

Concurrent Reactivation of Varicella Zoster Virus and Herpes Simplex Virus in an Immunocompetent Child
por: Park, Hyun-Ho, et al.
Publicado: (2004)

A Case of Severe Herpes Zoster and Varicella Occurring Simultaneously in an Aged Patient
por: Overton, R. E.
Publicado: (1926)

Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis
por: Manouchehrinia, Ali, et al.
Publicado: (2017)

Herpes zoster duplex bilateralis symmetricus in an immunocompromised patient with recent varicella infection
por: Amonchaisakda, Nuntouchaporn, et al.
Publicado: (2021)

1461. The Impact of Universal Varicella Vaccination on Herpes Zoster Incidence in the United States
por: Leung, Jessica W, et al.
Publicado: (2022)

Diagnostic Usefulness of Varicella Zoster Virus-Specific Immunoglobulin (Ig) A and IgG in Patients With Herpes Zoster
por: Choi, Sungim, et al.
Publicado: (2022)

Varicella Zoster Virus-Specific Hyperimmunoglobulin in the Adjuvant Treatment of Immunocompromised Herpes Zoster Patients: A Case Series
por: Terheyden, Patrick, et al.
Publicado: (2023)

Epidemiology of Varicella Zoster Virus and Herpes Zoster Virus in Gulf Cooperation Council Countries: A Review of the Literature
por: Badur, Selim, et al.
Publicado: (2022)

Herpes Zoster and Recurrent Herpes Zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2017)

Preventing varicella zoster infection in immunocompromised adults with varicella zoster–specific immunoglobulins
por: Gelman, Daniel, et al.
Publicado: (2023)

Varicella and Herpes Zoster in Madrid, based on the Sentinel General Practitioner Network: 1997–2004
por: Pérez-Farinós, Napoleón, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ta8u6ufs9hdp66idgco2nvmp50